ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors

Science

Volumn 314, Issue 5806, 2006, Pages 1792-1795

  Chen, Yu ^a   Corriden, Ross ^a,b   Inoue, Yoshiaki ^a   Yip, Linda ^a   Hashiguchi, Naoyuki ^a   Zinkernagel, Annelies ^d   Nizet, Victor ^d   Insel, Paul A ^b,c   Junger, Wolfgang G ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; FEEDBACK; NUCLEIC ACIDS; SIGNAL PROCESSING;

ADENOSINE TRIPHOSPHATE (ATP); CELL MIGRATION; CHEMOTACTIC GRADIENT FIELDS; GRADIENT SENSING; SIGNAL AMPLIFICATION;

CELL CULTURE;

ADENOSINE A3 RECEPTOR; ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; PURINE P2Y2 RECEPTOR; RECEPTOR; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE;

CHEMOTAXIS; NEUROLOGY; NUCLEIC ACID; ORGANIC PHOSPHORUS; SIGNAL;

ARTICLE; AUTOCRINE EFFECT; CELL MIGRATION; CELL SURFACE; EXTRACELLULAR MATRIX; FEEDBACK SYSTEM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; HYDROLYSIS; NEUTROPHIL CHEMOTAXIS; PRIORITY JOURNAL; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION;

ADENOSINE; ADENOSINE TRIPHOSPHATE; ANIMALS; AUTOCRINE COMMUNICATION; CELL MEMBRANE; CHEMOTAXIS, LEUKOCYTE; CYTOPLASMIC GRANULES; HL-60 CELLS; HUMANS; HYDROLYSIS; MICE; MICE, KNOCKOUT; NEUTROPHILS; RECEPTOR, ADENOSINE A3; RECEPTORS, PURINERGIC P2; SIGNAL TRANSDUCTION; SURAMIN;

EID: 33845708770     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.1132559     Document Type: Article

References (23)

1. S. J. Weiss, N. Engl. J. Med. 320, 365 (1989).
2. S. H. Zigmond, J. Cell Biol. 75, 606 (1977).
3. A. J. Ridley et al., Science 302, 1704 (2003).
4. P. J. Van Haastert, P. N. Devreotes, Nat. Rev. Mol. Cell Biol. 5, 626 (2004).
5. P. Bodin, G. Burnstock, Neurochem. Res. 26, 959 (2001).
6. G. Yegutkin, P. Bodin, G. Burnstock, Br. J. Pharmacol. 129, 921 (2000).
7. H. Zimmermann, Naunyn-Schmiedebergs Arch. Pharmakol. 362, 299 (2000).
8. B. B. Fredholm, Gen. Pharmacol. 28, 345 (1997).
9. Y. Chen, A. Shukla, S. Namiki, P. A. Insel, W. G. Junger, J. Leukocyte Biol. 76, 245 (2004).
10. G. Burnstock, G. E. Knight, Int. Rev. Cytol. 240, 31 (2004).
11. B. B. Fredholm, A. P. Ijzerman, K. A. Jacobson, K. N. Klotz, J. Linden, Pharmacol. Rev. 53, 527 (2001).
12. Y. Zhang, J. Palmblad, B. B. Fredholm, Biochem. Pharmacol. 51, 957 (1996).
13. A. B. Hauert, S. Martinelli, C. Marone, V. Niggli, Int. J. Biochem. Cell Biol. 34, 838 (2002).
14. G. Servant et al., Science 287, 1037 (2000).
15. G. P. Downey, Curr. Opin. Immunol. 6, 113 (1994).
16. J. K. Seo et al., J. Immunol. 158, 1895 (1997).
17. A. la Sala et al., J. Leukocyte Biol. 73, 339 (2003).
18. D. Knight et al., J. Leukocyte Biol. 62, 465 (1997).
19. B. A. Walker et al., Am. J. Respir. Cell Mol. Biol. 16, 531 (1997).
20. A. R. Kimmel, R. A. Firtel, Curr. Opin. Genet. Dev, 14, 540 (2004).
21. A. J. Ridley et al., Science 302, 1704 (2003).
22. M. Maeda et al., Science 304, 875 (2004).
23. This study was supported in part by National Institute of General Medical Sciences grants R01 GM-51477, GM-60475 (W.G.J.), and GM-66232 (P.A.I.), and by Congressionally Directed Medical Research Program grant PR043034 (W.G.J.).